These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36045927)

  • 1. Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium.
    Feldman PR; Feldman OJ; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():918058. PubMed ID: 36045927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Oct; 40():101124. PubMed ID: 34541479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
    Feldman PR; Gentile P; Piwko C; Motswaledi HM; Gorun S; Pesachov J; Markel M; Silver MI; Brenkel M; Feldman OJ; Kamen CL; Uleryk E; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():998623. PubMed ID: 36755885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.
    Whiting DA; Waldstreicher J; Sanchez M; Kaufman KD
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):282-4. PubMed ID: 10674382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders.
    Galal SA; El-Sayed SK; Henidy MMH
    J Clin Aesthet Dermatol; 2024 May; 17(5):15-22. PubMed ID: 38779373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study.
    Alessandrini AM; Bruni F; Piraccini BM; Starace M
    Dermatol Pract Concept; 2021 May; 11(3):e2021082. PubMed ID: 34123571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.
    Cedirian S; Bruni F; Quadrelli F; Caro G; Fortuna M; Rossi A; Piraccini BM; Starace M
    J Cosmet Dermatol; 2023 Dec; 22(12):3347-3351. PubMed ID: 37415302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair Shedding Evaluation for Alopecia: A Refined Wash Test.
    Li X; Wang X; Wang C; Zhang J; Zhou C
    Clin Cosmet Investig Dermatol; 2022; 15():117-126. PubMed ID: 35115799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogen Hairs in Women with and without Hair Loss.
    Guarrera M; Rebora A
    Skin Appendage Disord; 2017 Oct; 3(4):193-196. PubMed ID: 29177147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Dermoscopic Findings in Female Androgenetic Alopecia and Telogen Effluvium and Female Controls in a Tertiary Care Center.
    Bains P; Kaur S; Kaur K
    J Clin Aesthet Dermatol; 2022 May; 15(5):29-34. PubMed ID: 35642228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
    Whiting DA
    J Am Acad Dermatol; 1996 Dec; 35(6):899-906. PubMed ID: 8959948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature.
    Shimizu Y; Ntege EH; Sunami H; Inoue Y
    Regen Ther; 2022 Dec; 21():527-539. PubMed ID: 36382136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study.
    Rossi A; Magri F; DI Fraia M; Caro G; Fortuna MC; Piacentini M; Celleno L
    Ital J Dermatol Venerol; 2022 Feb; 157(1):78-83. PubMed ID: 33878855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium.
    Piccolo D; Crisman G; Conforti C; Buzzi M; Genovesi C; Marchi D; Mazzaracchio D; Goldust M
    Dermatol Ther; 2021 Mar; 34(2):e14799. PubMed ID: 33486860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.